Pancreatic Cancer Research

ResearcherZhejiang UniversityActive in the last 2 years

Rongzhen Xu

ORCID-verified (high confidence)As of 13 November 2026

Matched on ORCID iD 0000-0002-5865-0589; OpenAlex author ID A5066607822, A5091690894.

Their work

Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.

Pancreatic cancer papers
2 (first author 0, last author 1)
Pancreatic cancer trials
0
Pancreatic cancer grants
0
Labs led
1
Collaborators
2
Papers, trials and grants by year

2025: 1 paper · 2026: 1 paper

Papers 2

  1. HERV-K TM Subunit Elicits CD8+ T Cell Anergy and Tumor Immune Evasion via Targeting CD3 Coreceptor ε in AML and PDAC. Co-author DOI 10.1002/advs.202417432↗
  2. In vivo vaccine generation with a topical small molecule cocktail to eradicates AML and PDAC Last author DOI 10.1101/2025.10.19.683274↗

Closest collaborators

The 2 strongest of 2 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

  1. Shusen Zheng · 1 shared paper, 2025
  2. Mengyuan Li · 1 shared paper, 2026

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.